Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)

NCT03900858 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT03900858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03900858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2018
Completion date
June 1, 2022
Enrollment
566 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

silicosis tuberculosis